Brandon Capital Raises $180M Fund to Boost Australia and New Zealand Biotechs

talkbio0Tagged , , , , , , ,

1. Fund Amount: Brandon Capital has raised a $180 million (A$270 million) fund to support life sciences startups in Australia and New Zealand.
2. Focus: The fund will primarily focus on early-stage companies, helping them through the early growth stages.
3. Total Raised: Brandon Capital has raised a total of A$1 billion ($611 million) through five funds, supporting 60 investments in therapeutics, medical devices, and healthtech.
4. Portfolio Companies: Notable portfolio companies include Allay Therapeutics, AstronauTx, Aravex, and Certa Therapeutics.
5. Global Reach: Brandon Capital has been expanding its global reach, with previous investments in European biotechs, and now focusing on the Australasian region.
6. Limited Partners: The fund's limited partners include Australian superannuation (pension) funds and new investors.
7. Investment Goals: The fund aims to support the growth of life sciences startups, invest in scale-ups, and drive innovation in the region.

Leave a Reply

Your email address will not be published. Required fields are marked *